← Open Payments lookup

MELISSA MALINOSKI: Open Payments

NPI 1366814931 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$43,186 in 243 payments from 14 companies in 2025. Trend: 2023 $12,859 · 2024 $21,050 · 2025 $43,186

Speaker / faculty: $28,500Consulting: $6,898Food & beverage: $4,698Travel & lodging: $2,986Education: $104
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)59$23,093
Alkermes, Inc.39$9,098
ABBVIE INC.48$8,866
Neurocrine BioSciences, Inc.33$722
Otsuka America Pharmaceutical, Inc.20$497
Teva Pharmaceuticals USA, Inc.18$463
Supernus Pharmaceuticals, Inc.14$164
Inspire Medical Systems, Inc.1$92
Indivior Inc.4$67
Braeburn Inc.3$55

Products named: CAPLYTA, VRAYLAR, LYBALVI, INGREZZA, REXULTI, AUSTEDO XR, ARISTADA, Qelbree.

Industry payments across MI — which companies pay providers there.